Dual diagnosis treatment for Hollywood — one team, both diagnoses, together.

Hollywood is 35 miles up I-95 from RECO Health's Delray Beach campus — a 50-minute drive that lets clients separate treatment from the neighborhoods and cues tied to active use. Dual diagnosis is handled by a single in-house team: the same addiction psychiatrist manages buprenorphine or naltrexone alongside the SSRI, mood stabilizer, or ADHD medication, and the same primary therapist addresses the substance use timeline and the trauma history. On-site TMS, ketamine, and psychiatry mean the referral-driven breakpoints that fragment most dual diagnosis care do not exist here.

Hollywood sits 35 miles down I-95 from RECO Health’s Delray Beach campus — a 50-minute drive outside rush hour, closer to 75 minutes at peak. For clients living in Hollywood Beach, Emerald Hills, Hollywood Lakes, Hollywood Hills, or Oakwood, that distance is less a logistical burden than a clinical feature: pairing partial hospitalization with on-site sober living in Delray creates physical separation from the neighborhoods, contacts, and cues tied to active use, without giving up the family and life waiting back home.

Why sequential treatment fails for co-occurring disorders

The evidence on sequential treatment — “get sober first, then we’ll address the mental health” — has been unambiguous for two decades. Untreated depression during early recovery predicts relapse inside 90 days; untreated substance use during a depressive episode blunts SSRI response and inflates suicide risk. Substance use disorder and psychiatric illness are not adjacent problems to be handled by separate providers on different timelines. They are entangled at the level of neurobiology, cognition, and behavior, and they must be treated on a single integrated plan by clinicians credentialed in both.

At RECO Health, integration is operationalized rather than advertised. The same psychiatrist writes the buprenorphine and the sertraline. The same primary therapist runs the individual sessions that address both the substance use timeline and the trauma history. Case conceptualization draws from all six ASAM Criteria dimensions — including Dimension 3, emotional/behavioral/cognitive conditions — so psychiatric acuity is weighted against withdrawal risk and relapse potential from admission forward.

Sequential care also fragments accountability. When one provider owns the addiction and another owns the depression, neither owns the outcome. Integrated dual diagnosis treatment collapses that gap, and it is the standard of care articulated by SAMHSA, the American Society of Addiction Medicine, and the American Psychiatric Association — not a differentiator.

The high-prevalence co-occurring diagnoses

Major depressive disorder, PTSD, generalized anxiety disorder, bipolar disorder, and adult ADHD account for the majority of psychiatric diagnoses that co-occur with substance use disorder. RECO screens for all five at intake using validated instruments — the PHQ-9 for depression, PCL-5 for PTSD, GAD-7 for anxiety, MDQ for bipolar spectrum, and ASRS for adult ADHD — supplemented by structured psychiatric interview to differentiate substance-induced mood states from primary psychiatric illness.

Each diagnosis carries a defined evidence-based pathway inside the program:

• Depression — SSRI or SNRI paired with CBT and behavioral activation; treatment-resistant presentations evaluated for esketamine, IV ketamine, or rTMS delivered at 3000 pulses per session at 120% of motor threshold.
• PTSD — cognitive processing therapy, prolonged exposure, or EMDR, initiated once the client’s window of tolerance can support processing.
• Bipolar disorder — mood stabilizer optimization with lithium, lamotrigine, quetiapine, or aripiprazole, plus targeted psychoeducation and sleep-wake regulation.
• Adult ADHD — non-stimulant first-line (atomoxetine, bupropion); carefully monitored stimulants only after sustained abstinence and structured accountability.
• Generalized anxiety — CBT and ACT with SSRI or buspirone; benzodiazepines avoided in early recovery outside medically supervised detox.

OCD presentations are screened with the Y-BOCS and treated with exposure and response prevention plus SSRI at anti-obsessional doses. Substance-induced versus primary distinction is revisited at 30 days sober because presentations often reshape once withdrawal and post-acute symptoms clear.

MAT and psychotropic medication managed by one psychiatrist

Medication-assisted treatment and psychiatric medication are prescribed by the same in-house addiction psychiatrist. For opioid use disorder, that means buprenorphine — initiated after a COWS-documented withdrawal window — or extended-release naltrexone. For alcohol use disorder, naltrexone or acamprosate, with disulfiram considered for the right candidate. These agents are dosed alongside and titrated against the client’s antidepressant, mood stabilizer, or anxiolytic, with drug interactions checked and QT prolongation, serotonin syndrome risk, and hepatic burden actively managed.

Fragmented prescribing is one of the most common relapse pathways in dual diagnosis populations. A primary care doctor titrating an SSRI, an outside psychiatrist adjusting quetiapine, and an MAT provider dosing buprenorphine — none of them in communication — is a setup for destabilization, diversion, or both. RECO’s model closes that gap by centralizing prescribing in a single clinician who owns both the addiction and the psychiatric formulation.

Medication decisions are anchored to measurement rather than impression. PHQ-9 and GAD-7 are re-administered on a defined cadence; cravings, sleep, appetite, and side-effect burden are documented. Adjustments are data-driven and dose changes are titrated deliberately, not stacked.

Trauma is often the through-line

For a substantial share of clients presenting with dual diagnoses, unprocessed trauma sits upstream of both the substance use and the mood disorder. The substance use functions as an anesthetic; the depression or anxiety is the residue. Treating either without addressing the trauma tends to work short-term and fail long-term.

RECO screens for trauma at intake using the PCL-5 and adverse childhood experiences questioning, then stabilizes before processing. Early-phase work emphasizes affect regulation, grounding, and somatic skills that expand the window of tolerance — DBT distress tolerance modules, sensorimotor grounding, and psychoeducation about the neurobiology of trauma. Only when a client can stay regulated does the clinical team move into cognitive processing therapy, prolonged exposure, or EMDR.

For clients whose trauma memories remain acutely intrusive after standard trauma-focused therapy, adjunctive interventions — including ketamine-assisted psychotherapy protocols and rTMS for comorbid treatment-resistant depression — are delivered on-site. That matters clinically: referral out to specialty care is a common breakpoint where dual diagnosis clients disengage.

What to expect during the first week

Admission from Hollywood typically starts with a phone assessment and benefits verification and, where clinically indicated, direct transport to detox. The first 24 to 72 hours are medically driven: CIWA-Ar scoring for alcohol withdrawal, COWS scoring for opioid withdrawal, and medically supervised tapers for benzodiazepines. Psychiatric consultation happens inside the first 72 hours, and standing psychotropic medications are reconciled, restarted, or adjusted rather than abruptly discontinued.

Once medically stable, the client transitions into residential or partial hospitalization. A primary therapist is assigned, a case manager arranges on-site sober living for Hollywood clients who are not commuting daily, and an integrated treatment plan is drafted with input from psychiatry, therapy, family services, and the client. Group programming begins immediately — process groups, CBT and DBT skills, relapse prevention, and diagnosis-specific tracks in trauma, mood, and dual diagnosis run daily.

Insurance and admissions from Hollywood

RECO Health is in-network with Florida Blue, Aetna, Cigna, UnitedHealthcare, Humana, and BCBS plans, and integrated dual diagnosis care is covered under behavioral health benefits on the vast majority of commercial plans at the levels of care RECO operates. Admissions completes a full benefits verification — deductible, out-of-pocket maximum, coinsurance, and prior authorization requirements — before any financial commitment is asked of the client or family.

Hollywood clients typically move through the continuum in Delray rather than commuting: detox and residential on-campus, PHP with on-site sober living, then IOP as clinical acuity decreases. That trajectory is what the 35 miles up I-95 actually purchase — the physical distance from the neighborhoods, people, and cues that shaped active use, without severing the family and community waiting at home.

Serving residents of: Hollywood Beach, Emerald Hills, Hollywood Lakes, Hollywood Hills, Oakwood.